Your search for "Skin" found 5 matches:
|
A Randomized, Double-Blinded, Placebo-Controlled Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adult Patients With Pemphigus (Vulgaris or Foliaceus) (ADDRESS)
Protocol #: 20-2721
Locations: Outpatient CTRC; University of Colorado Hospital
|
A Phase 2 Open-Label Study of PTR-01 in Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Protocol #: 20-1938
Location: Childrens Hospital Colorado
|
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Immune-Mediated Inflammatory Skin Conditions
Protocol #: 20-0124
Location: University of Colorado Hospital
|
Safety and efficacy of tofacitinib for immune skin conditions in Down syndrome
This study is designed to determine whether tofacitinib is a safe and effective treatment for immune skin conditions in adults with Down syndrome, and to further our understanding of the immune system in Down syndrome.
This is a single arm, open-label study. All participants will receiv...more >
Protocol #: 19-1362
Locations: Outpatient CTRC; University of Colorado Hospital
|
A Phase IA/IB Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of RO7198457 as a Single Agent and in Combination with Atezolizumab in Patients with Locally Advanced or Metastatic Tumors
Protocol #: 17-0991
Locations: Lone Tree Medical Center; University of Colorado Hospital
|